Company Info
| Industry | Biotechnology |
|---|---|
| Sector | Health Technology |
| Employees | 2,092 |
| CEO | Dr. Clay B. Siegall |
| Address | 21823-30th Drive SE , Bothell, WA 98021 |
|---|---|
| Phone | 1.425.527.4000 |
| Website | www.seattlegenetics.com |
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.
Statement Summary
as of 4:00 ET PM 01/20/2022| Total Assets (MRQ) | 4.0 B |
|---|---|
| Total Liabilities (MRQ) | 812.9 M |
| Shareholders’ Equity (MRQ) | 3.2 B |
| Total Revenue (Annual) | 424.1 M |
| Net Income (Annual) | -293.8 M |
Earnings And Estimates
as of 4:00 ET PM 01/20/2022
| Current Qtr EPS Estimate | -0.82 |
|---|---|
| Current FY EPS Estimate | -3.55 |
| Long Term EPS Growth Estimate | 15.05 |
| Next Expected Earnings Date | // |
SGEN vs S&P 500
as of 01/20/2022| Relative To S&P 500 |
SGEN | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:00 ET PM 01/20/2022| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/2021 | -0.58 | -1.61 | +179.60% |
| 06/2021 | -0.61 | -0.47 | -23.23% |
| 03/2021 | -0.61 | -0.67 | +9.50% |
| 12/2020 | 0.89 | 0.90 | +1.12% |
| 09/2020 | -0.40 | 3.50 | -973.44% |
| 06/2020 | -0.60 | -0.12 | -80.02% |
| 03/2020 | -0.75 | -0.98 | +29.95% |
| 12/2019 | -0.50 | 0.14 | -128.22% |
Financial Strength
as of 4:00 ET PM 01/20/2022| Pre-Tax Margin | -69.03 |
|---|---|
| Net Margin | -215.65 |
| Operating Margin | -70.26 |
| Return On Equity | -12.27 |
| Return On Assets | -9.53 |
| Inventory Turnover (TTM) | 2.06 |
| Sales Growth (MRQ) | 45.22 |
Ratios
as of 4:00 PM ET 01/20/2022| Price/Earnings (TTM) | n/a |
|---|---|
| Price/Book (MRQ) | 7.37 |
| Price/Cash Flow (TTM) | 0.00 |
| Book Value (MRQ) | 17.31 |
| Quick Ratio (MRQ) | 4.20 |
| Current Ratio (MRQ) | 4.46 |
| Total Debt/Equity (MRQ) | 0.02 |
Short Interest
as of 4:00 PM ET 01/21/2022| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:00 ET PM 01/20/2022| Current Qtr (12/2021) |
Next Qtr (03/2022) |
|
|---|---|---|
| Consensus Estimate | $-0.82 | $-0.45 |
| # of Estimates | 16 | 8 |
| High Estimate | $-0.54 | $-0.09 |
| Low Estimate | $-1.15 | $-0.70 |
| Year Ago EPS | $0.93 | $-0.67 |
| Year Over Year Growth Estimate | -187.49% | -33.22% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $-3.55 | $-1.03 |
| # of Estimates | 19 | 19 |
| High Estimate | $-3.29 | $0.31 |
| Low Estimate | $-3.89 | $-2.38 |
| Year Ago EPS | $3.37 | $-3.55 |
| Year Over Year Growth Estimate | -205.36% | -71.11% |
| Current Qtr (12/2021) |
Next Qtr (03/2022) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $-0.82 | $-0.45 | $-3.55 | $-1.03 |
| # of Estimates | 16 | 8 | 19 | 19 |
| High Estimate | $-0.54 | $-0.09 | $-3.29 | $0.31 |
| Low Estimate | $-1.15 | $-0.70 | $-3.89 | $-2.38 |
| Year Ago EPS | $0.93 | $-0.67 | $3.37 | $-3.55 |
| Year Over Year Growth Estimate | -187.49% | -33.22% | -205.36% | -71.11% |
Insider Information Summary
as of 12/31/1969| % Insiders - 1.11% | |
| % Remaining Total Shares - 98.89% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | -393.04 K | -332.29 K |
| Shares Bought | 166.05 K | 131.57 K |
| Shares Sold | 559.09 K | 463.86 K |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Latest News
Pieris Pharma Wavers After $13M Seagen Equity Investment
Mar 25, 2021 12:17 PM EDT
Buy-the-Dip Candidates in the Stock Market: Tesla, Palantir
Feb 16, 2021 8:14 AM EST
Bumble, Tilray, Disney, PepsiCo and Pinterest - 5 Things You Must Know Thursday
Feb 11, 2021 5:04 AM EST
5 Worst Stocks in the Nasdaq on Wednesday: Moderna Slides Again
Dec 30, 2020 6:15 PM EST
7 Worst Stocks in the Nasdaq on Wednesday: Zoom Sinks
Dec 23, 2020 1:40 PM EST
Recommended for You
Covid Omicron Strains Food Supply as Workers Are Sickened
Food-industry executives say the pressure could continue for some time, even after the Covid omicron variant passes, a media report says.
13 minutes ago
Recent Articles from TheStreet
Covid Omicron Strains Food Supply as Workers Are Sickened
Food-industry executives say the pressure could continue for some time, even after the Covid omicron variant passes, a media report says.
Buffett and Wood Produce Similar Two-Year Returns
Buffett did it with gradual, consistent returns, while Wood saw a major surge followed by a sharp downturn.
Snap Stock Tumbles After Rating, Price Target Cut From Wedbush Ahead of Q4 Earnings
Snap shares tumbled after analysts at Wedbush cut their rating and price target on the message app maker.
Stock Market Today - 1/24: S&P 500 Slumps Into Correction Territory Amid Russia Tensions, Fed Rate Concerns
U.S. stocks are set to extend declines from their worst week since the 2020 pandemic Monday ahead of a key series of big tech earnings reports and a crucial statement from the Federal Reserve.
Wait! There’s Good News on Inflation?
Look at a certain way, the recent PPI numbers could be signaling the turning point in pandemic-led inflation pressures, according to the Action Alerts Plus team.
Tale of the Tape: Comparing Roth IRAs and Roth 401(k)s
What's the best strategy if a client lacks the funds to contribute to both a Roth IRA and a Roth 401(k)? Here's a breakdown of the advantages each option has to offer.
Why Is Bitcoin Crashing? Ask the Stock Market
Bitcoin is down another 8% amid a broader selloff that has seen the digital token shed a quarter of its value in January alone. The stock market knows why.
Peloton Stock Slides Amid Reports Of Activist Pressure To Fire CEO John Foley, Explore Company Sale
Blackwells Capital is reportedly pushing for big changes at Peloton, including the ouster of CEO John Foley, following last week's multi-billion dollar selloff in the group's stock.
Kohl's Stock Soars After Second Takeover Offer For Activist-Target Retailer
Two reported activist-lead takeover offers for Kohl's has shares in the struggling department store retailer soaring Monday.
A Skeptic's Take on Delta's Forecast of 'Meaningful Profit'
Delta Airlines could face additional challenges in 2022 as the coronavirus and fuel inflation continue to affect travel, argues Stephen “Sarge” Guilfoyle.